{"id":4513,"date":"2025-03-31T18:12:10","date_gmt":"2025-03-31T18:12:10","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/hydralazine-hydrochloride-txt\/"},"modified":"2025-03-31T18:12:10","modified_gmt":"2025-03-31T18:12:10","slug":"hydralazine-hydrochloride-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/hydralazine-hydrochloride-txt\/","title":{"rendered":"hydralazine hydrochloride.txt"},"content":{"rendered":"<h1>  hydralazine hydrochloride  <\/h1>\n<p><H3>  CLINICAL USE <\/H3><br \/>\nVasodilator antihypertensive agent<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>Oral: Hypertension: 25\u201350 mg twice daily;  \u2014maximum daily dose 100 mg in women and slow acetylators, 200 mg in fast acetylatorsHeart failure: 25\u201375 mg 3\u20134 times daily \u2014IV: slow IV injection: 5\u201310 mg over  20 minutes; repeat after 20\u201330 minutes if necessaryInfusion: 200\u2013300 micrograms\/minute  initially, reducing to 50\u2013150 micrograms\/minute<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :196.6<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :87<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 2\u201314<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :0.5\u20130.9<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :2\u20134\/16<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4><LI> 20 to 50  &amp;nbsp &amp;nbsp : Start at low dose and adjust in accordance with response<LI> 10 to 20  &amp;nbsp &amp;nbsp : Start at low dose and adjust in accordance with response<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Start at low dose and adjust in accordance with response<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Not dialysed. Dose as in GFR &lt;10 mL\/min <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Not dialysed. Dose as in GFR &lt;10 mL\/min <LI>HDF\/high flux  &amp;nbsp :Not dialysed. Dose as in GFR &lt;10 mL\/min<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Not dialysed. Dose as in GFR=10\u201320 mL\/min<H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugs\n<li>     Anaesthetics: increased hypotensive  effects<H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>20 mg with 1 mL water for injection then  dilute with 10 mL sodium chloride 0.9% for IV injection or 500 mL sodium chloride 0.9% for <H4> IV infusion  <\/H4><H4>  Route  <\/H4>Oral, IV peripherally <H4>  Rate of Administration  <\/H4>As above <H4>Comments<\/H4>Minimum volume of 60 mg in 60 mL. <H4>  OTHER INFORMATION  <\/H4>Avoid long-term use in severe renal  insufficiency and dialysis patients, due to accumulation of metaboliteshydralazine hydrochloride.<br \/>\n","protected":false},"excerpt":{"rendered":"<p>hydralazine hydrochloride CLINICAL USE Vasodilator antihypertensive agent DOSE IN NORMAL<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4513","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4513"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4513\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}